J. M. A. Lange - Concepedia

Author

J. M. A. Lange

University of Amsterdam

Also Known As

J M Lange, J. M. A. Lange, J.M.A. Lange, J. M. A. Lange, Joep M. A. Lange, JoepMA Lange, Jordan Lange

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Amsterdam UMC Location University of Amsterdam Dutch Blood Transfusion Society Institute of Virology of the Slovak Academy of Sciences Department of Virology

About

J. M. A. Lange is an author at University of Amsterdam specializing in medicine, hiv, and primary immunodeficiency.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.1K
2	Health Sciences	1	1	73
3	Public Health	1	1	14
4	Social Sciences	1	1	137
5	Allergy	1	1	137

J. M. A. Lange

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients Julio Montaner, David A. Cooper, Stefano Vella, JAMA	1998	771
Ordered Appearance of Zidovudine Resistance Mutations during Treatment of 18 Human Immunodeficiency Virus-Positive Subjects Charles A. Boucher, E O'Sullivan, Jan W. Mulder, The Journal of Infectious Diseases Primary ImmunodeficiencyResistant VirusHuman RetrovirusGeneticsPathogenesis	1992	362
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. J. M. A. Lange, Deborah A. Paul, Han G. Huisman, BMJ ImmunologyActive Hiv InfectionSerum SamplesHiv Core AntibodiesViral Persistence	1986	342
Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. F. de Wolf, Jaap Goudsmit, Deborah A. Paul, BMJ ImmunologyHomosexualityHuman Immunodeficiency VirusSocial SciencesHuman Retrovirus	1987	137
Conversion Rate towards a Syncytium‐Inducing (SI) Phenotype during Different Stages of Human Immunodeficiency Virus Type 1 Infection and Prognostic Value of SI Phenotype for Survival after AIDS Diagnosis M. Koot, Remko van Leeuwen, R. E. Y. de Goede, The Journal of Infectious Diseases	1999	105
Response Classification Based on a Minimal Model of Glioblastoma Growth Is Prognostic for Clinical Outcomes and Distinguishes Progression from Pseudoprogression Maxwell L. Neal, Andrew D. Trister, Sunyoung Ahn, Cancer Research Minimal ModelCancer ManagementPrognosisDays GainedPathology	2013	73
Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition. Ireneus P.M. Keet, F K Lee, Frits van Griensven, Sexually Transmitted Infections Primary ImmunodeficiencySexual HealthHiv-1 AcquisitionViral PersistenceHuman Retrovirus	1990	71
Dehydroepiandrosterone as Predictor for Progression to AIDS in Asymptomatic Human Immunodeficiency Virus-Infected Men Jan W. Mulder, P. H. J. Frissen, Pieta Krijnen, The Journal of Infectious Diseases	1992	65
Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates Charles A. Boucher, Remko van Leeuwen, Paul Kellam, Antimicrobial Agents and Chemotherapy Primary ImmunodeficiencyHuman RetrovirusImmunologyAntiviral Drug DevelopmentResistance Mutation (Virology)	1993	50
Zidovudine and Interferon- Combination Therapy versus Zidovudine Monotherapy in Subjects with Symptomatic Human Immunodeficiency Virus Type 1 Infection P. H. J. Frissen, Marc van der Valk, Chris H.H. ten Napel, The Journal of Infectious Diseases	1994	33

Page 1